AmCad BioMed Corporation (TPEX:4188)
Taiwan · Delayed Price · Currency is TWD 14.00
+0.20 (1.45%)
Sep 18, 2026, 1:30 PM CST
AmCad BioMed Market Cap
AmCad BioMed has a market cap or net worth of 874 million as of September 17, 2026. Its market cap has decreased by -10.97% in one year.
Market Cap
874.00M
Enterprise Value
617.95M
Revenue
28.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.00
ChartMarket Cap Chart
Since December 26, 2013, AmCad BioMed's market cap has decreased from 905.63M to 874.00M, a decrease of -3.49%. That is a compound annual growth rate of -0.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 874.00M | -6.12% |
| Dec 31, 2025 | 930.99M | -34.23% |
| Dec 31, 2024 | 1.42B | -0.45% |
| Dec 29, 2023 | 1.42B | 67.51% |
| Dec 30, 2022 | 848.88M | -17.57% |
| Dec 30, 2021 | 1.03B | 0.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Taiwan Biomaterial | 1.51B |
| AViTA | 1.37B |
| Bioptik Technology Incorporation | 1.33B |
| S&S Healthcare Holding | 1.20B |
| Rossmax International | 1.05B |
| Wiltrom | 965.88M |
| Diamond Biotechnology | 804.89M |
| Cowealth Medical Holding | 771.47M |